SandboxAlonso: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
 
(63 intermediate revisions by the same user not shown)
Line 1: Line 1:
==Stage IV==
__NOTOC__
{{CMG}}; {{AE}} {{Alonso}}


{{familytree/start}}
Infobox goes here
{{familytree | | | | | | | A01 | | | | | A01=Is [[Pleural effusion|pleural]] or [[pericardial effusion]] present (suggestive of M1a) or are findings suggestive of systemic [[metastasis]] (M1b) present?}}
{{familytree | | | |,|-|-|-|^|-|-|-|.| | |}}
{{familytree | | | B01 | | | | | | B02 | B01=M1a|B02=M1b: solitary site systemic [[metastasis]]}}
{{familytree | | | |!| | | | | | | |!| | | |}}
{{familytree | | | C01 | | | | | | C02 | | | C01=<div style="float: left; text-align: left; width: 14em; padding:1em;">Perform the following tests:<br>
* Perform [[thoracentesis]] and/or [[pericardiocenteis]]<br>
* Perform a [[thoracoscopy]] if [[thoracocentesis]] is inconclusive
</div>|C02=<div style="float: left; text-align: left; width: 14em; padding:1em;">Perform the following tests:<br>
* [[Brain tumor MRI|Brain MRI]]<br>
* [[Bronchoscopy]]<br>
* Mediastinal [[lymph node biopsy]]<br>
* If not previously done, [[PET scan]] or [[CT scan]]</div>}}
{{familytree | | | |!| | | | | | | |!| | | | |}}
{{familytree | | | D01 | | | | | | D02 | | | | D01=Is the liquid extracted positive for malignant cells?|D02=Are findings suggestive of  [[adrenal]] metastasis or [[brain]] metastasis?}}
{{familytree | |,|-|^|-|.| | | |,|-|^|-|.| | | |}}
{{familytree | E01 | | E02 | | E03 | | E04 | | | E01=Yes|E02=No|E03=[[Adrenal]]|E04=[[Brain]]}}
{{familytree | |!| | | |!| | | |!| | | |!| | |}}
{{familytree | F01 | | F02 | | F03 | | F04 | | F01=<div style="float: left; text-align: left; width: 14em; padding:1em;">Local therapy<br>
* Ambulatory catheter drainage<br>
* [[Pleurodesis]]<br>
* Mediastinal window<br>
PLUS<br>
Therapy for metastatic disease (click here for the treatment of local and systemic metastasis and neoplastic recurrence)
</div>|F02=<div style="float: left; text-align: left; width: 14em; padding:1em;">Treat according to tumor stage:<br>
* [[Non small cell carcinoma of the lung medical therapy#Stage I|I]]<br>
* [[Non small cell carcinoma of the lung medical therapy#Stage II|II]]<br>
* [[Non small cell carcinoma of the lung medical therapy#Stage III|III]]<br>
</div>|F03=Perform a [[needle aspiration biopsy]] for metastasis confirmation|F04=<div style="float: left; text-align: left; width: 14em; padding:1em;">Surgical resection + adjuvant radiation therapy<br>Radiation therapy alone:<br>
* Sterotactic radio surgery + Whole brain radiation therapy<br>OR<br>
* Sterotactic radio surgery alone<br>
PLUS<br>
Pathologic evaluation of surgical piece and [[lymph nodes]]</div>}}
{{familytree | | | | | | | | | |!| | | |!| | | | | | | |}}
{{familytree | | | | | | | | | G01 | | G02 | | | | | | | G01=<div style="float: left; text-align: left; width: 14em; padding:1em;">If the [[lung]] disease is curable, administer local therapy for the [[adrenal]] lesion:<br>
* Surgical [[adrenal]] resection<br>OR<br>
* Radiation therapy<br>
OR<br>
Administer therapy for metastatic disease in case of not curable lung lesions (click here for the treatment of local and systemic metastasis and neoplastic recurrence)
</div>|G02=What is the TN stage of the lung [[tumor]]?}}
{{familytree | | | | | | | | | | | |,|-|^|-|.| | |}}
{{familytree | | | | | | | | | | | H01 | | H02 | | | | | H01=<div style="float: left; text-align: left; width: 14em; padding:1em;">
* T1-2, No-1<br>
* T3, N0
</div>|H02=<div style="float: left; text-align: left; width: 14em; padding:1em;">
* T1-2, N2<br>
* T3, N1-2<br>
* N3, regardless of the T stage<br>
* T4 regardless of the N stage</div>}}
{{familytree | | | | | | | | | | | |!| | | |!| | | | | | |}}
{{familytree | | | | | | | | | | | I01 | | I02 | | | | I01=<div style="float: left; text-align: left; width: 14em; padding:1em;">
* Surgical resection of lung [[tumor]] + adjuvant chemotherapy<br>OR<br>
* Neoadjuvant chemotherapy + surgical resection or stereotactic ablative radiation therapy<br>OR<br>
* Stereotactic ablative radiation therpay alone</div>
|I02=<div style="float: left; text-align: left; width: 14em; padding:1em;">Administer therapy for metastatic disease in case of not curable lung lesions (click here for the treatment of local and systemic metastasis and neoplastic recurrence)</div>}}
{{familytree/end}}
<br>


==Multiple lung cancers==
<nowiki>{{SI}}</nowiki>


{{familytree/start}}
'''''Synonyms and keywords:'''''
{{familytree | | | | | | | | | A01 | | | | A01=Is there suspicion of multiple lung cancers?}}
{{familytree | | | | | | | |,|-|^|-|.| | |}}
{{familytree | | | | | | | B01 | | B02 | | | B01=Yes|B02=No}}
{{familytree | | | | | | | |!| | | |!| | | | |}}
{{familytree | | | | | | | C01 | | C02 | | | | C01=<div style="text-align: left; padding:1em;">Perform the following tests:<br>
* If not previously done, [[PET scan]] or [[CT scan]]<br>
* Contrast chest [[CT]]<br>
* [[Brain tumor MRI|Brain MRI]]
</div>|C02=Administer treatment according to the TNM stage of the [[tumor]]}}
{{familytree | | | | | | | |!| | | | | | | |}}
{{familytree | | | | | | | D01 | | | | | D01=Is the disease is confined to the [[chest]] or is there systemic proliferation?}}
{{familytree | | | | | |,|-|^|-|.| | | | |}}
{{familytree | | | | | E01 | | E02 | | | | E01=Disease confined to the [[chest]]|E02=Systemic proliferation}}
{{familytree | | | | | |!| | | |!| | | |}}
{{familytree | | | | | F01 | | F02 | | | F01=Assess the [[mediastinal]] [[lymph nodes]] in order to determine the N stage of the [[tumor]]|F02=Click here for the treatment of systemic metastasis}}
{{familytree | | | | | |!| | | | | |}}
{{familytree | | | | | G01 | | | | | G01=What is the N stage of the [[tumor]]?}}
{{familytree | | | |,|-|^|-|.| | |}}
{{familytree | | | H01 | | H02 | | | H01=N0-1|H02=N2-3}}
{{familytree | | | |!| | | |!| | | |}}
{{familytree | | | I01 | | I02 | | | I01=Is the patient symptomatic?|I02=Click here for the treatment of systemic metastasis}}
{{familytree | |,|-|^|-|.| | | | | |}}
{{familytree | J01 | | J02 | | | | | J01=Yes|J02=No}}
{{familytree | |!| | | |!| | | | | |}}
{{familytree | |!| | | K01 | | | | | K01=Is the lesion a solitary nodule or are there multiple nodules?}}
{{familytree | |!| |,|-|^|-|.| | |}}
{{familytree | |!| L01 | | L02 | | L01=Solitary nodule|L02=Multiple nodules}}
{{familytree | |!| |!| | | |!| | |}}
{{familytree | |!| |!| | | M01 | | | M01=What is the risk of turning into a symptomatic disease?}}
{{familytree | |!| |!| |,|-|^|-|.| |}}
{{familytree | |!| |!| N01 | | N02 | |N01=High|N02=Low}}
{{familytree | |`|-|+|-|'| | | |!| | |}}
{{familytree | | | O01 | | | | O02 | | O01=Is definitive local therapy possible?|O02=Observation}}
{{familytree | |,|-|^|-|.| | | |!| | | |}}
{{familytree | P01 | | P02 | | |!| | | | P01=No|P02=Yes}}
{{familytree | |!| | | |!| | | |!| | | |}}
{{familytree | Q01 | | Q02 | | |!| | | | Q01=Consider palliative chemotherapy with or without local radiation therapy|Q02=<div style="text-align: left; padding:1em;">Administer one of the following tratments:<br>
* Preferred option: Parenchymal sparing resection<br>
* Radiation therapy<br>
* Ablatipn therapy</div>}}
{{familytree | |!| | | |`|-|v|-|'| | | |}}
{{familytree | R01 | | | | R02 | | | | R01=Click here for the treatment of systemic metastasis|R02=Click here for the follow-up recommendations and treatment of recurrence and metastasis}}
{{familytree/end}}


==Follow-up==
== Overview ==
'''Body dysmorphic disorder (BDD)''' is a mental disorder that involves a disturbed [[body image]]. It is generally diagnosed in those who are extremely critical of their physique or self-image, despite the fact there may be no noticeable disfigurement or defect.


{{familytree/start}}
Most people wish they could change or improve some aspect of their physical appearance, but people suffering from BDD, generally considered of normal appearance, believe that they are so unspeakably hideous that they are unable to interact with others or function normally for fear of ridicule and humiliation at their appearance. They tend to be very secretive and reluctant to seek help because they are afraid others will think them vanity|vain or they may feel too embarrassed to do so.
{{familytree | | | | | A01 | | | | | A01=Controls of history + physical exam and chest [[CT]] with or without contrast every 6-12 months (first 2 years), then annual controls}}
{{familytree | | | | | |!| | | | | | |}}
{{familytree | | | | | B01 | | | | | B01=Is there evidence of local or regional recurrence<br>OR<br>systemic [[metastasis]]?}}
{{familytree | | | |,|-|^|-|.| | | |}}
{{familytree | | | C01 | | C02 | | | C01=Local or regional recurrence|C02=Systemic [[metastasis]]}}
{{familytree/end}}


===Local or regional recurrence===
Ironically, BDD is often misunderstood as a vanity driven obsession, whereas it is quite the opposite; people with BDD believe themselves to be irrevocably ugly or defective.  
{{familytree/start}}
{{familytree | | | | | | | | | A01 | | | | | | | | | | A01=What is the site of the recurrence?}}
{{familytree | |,|-|-|-|v|-|-|-|+|-|-|-|v|-|-|-|.| | |}}
{{familytree | B01 | | B02 | | B03 | | B04 | | B05 | | | B01=[[Bronchus|Bronchial]] obstruction|B02=Mediastinal [[lymph node]]|B03=[[Superior vena cava]] obstruction|B04=Severe [[hemoptisis]]|B05=Resectable [[tumor]]}}
{{familytree | |!| | | |!| | | |!| | | |!| | | |!| | | |}}
{{familytree | C01 | | C02 | | C03 | | C04 | | C05 | | C01=Surgical correction of the obstruction: laser therapy, stent or any other surgical procedure<br>OR<br>Radiation therapy (external-beam or brachytherapy)<br>OR<br>Photodynamic therapy|C02=Has the patient received [[radiation therapy]]?|C03=Chemotherapy + radiation therapy<br>OR<br>External-beam radiation therapy<br>OR<br>[[Superior vena cava]] stent collocation|C04=Surgery<br>OR<br>Radiation therapy (external-beam or brachytherapy)<br>OR<br>Laser therapy, photodynamic therapy or tumor [[embolization]]|C05=[[Tumor]] resection (preferred option)<br>OR<br>Radiation therapy (stereotactic ablative radiotherapy or external-beam radiation therapy)}}
{{familytree | |!| |,|-|^|-|.| |!| | | |!| | | |!| | | |}}
{{familytree | |!| D01 | | D02 |!| | | |!| | | |!| | | D01=Yes|D02=No}}
{{familytree | |!| |!| | | |!| |!| | | |!| | | |!| | | |}}
{{familytree | |!| E01 | | E02 |!| | | |!| | | |!| | | | E01=Administer systemic therapy|E02=Administer chemotherapy + radiation therapy}}
{{familytree | |`|-|^|-|-|-|^|-|+|-|-|-|^|-|-|-|'| | | |}}
{{familytree | | | | | | | | | F01 | | | | | | | | | | | F01=Are findings suggestive of disseminated disease present?}}
{{familytree | | | | | | |,|-|-|^|-|-|.| | | | |}}
{{familytree | | | | | | G01 | | | | G02 | | | | | G01=Yes|G02=No}}
{{familytree | | | | | | |!| | | | | |!| | | | | |}}
{{familytree | | | | | | H01 | | | | H02 | | | | | H01=Click here for the treatment of metastatic disease|H02=Observation<br>OR<br>systemic therapy}}
{{familytree/end}}
<br>


===Systemic metastasis===
BDD combines obsessive and compulsive aspects, which links it to the [[Obsessive-Compulsive Disorder|OCD]] spectrum disorders among psychologists. People with BDD may engage in compulsive mirror checking behaviors or mirror avoidance, typically think about their appearance for more than one hour a day, and in severe cases may drop all social contact and responsibilities as they become homebound. The disorder is linked to an unusually high [[suicide]] rate among all mental disorders.
{{familytree/start}}
{{familytree | | | | | | | | | A01 | | | | | | | | | | A01=What are the characteristics of the [[metastasis]]?}}
{{familytree | |,|-|-|-|v|-|-|-|+|-|-|-|v|-|-|-|.| | |}}
{{familytree | B01 | | B02 | | B03 | | B04 | | B05 | | | B01=Diffuse [[brain]] metastasis|B02=[[Bone]] metastasis|B03=Localized symptoms||B04=Solitary [[metastasis]]|B05=Multiple [[metastasis]]}}
{{familytree | |!| | | |!| | | |!| | | |!| | | |!| | | |}}
{{familytree | C01 | | C02 | | C03 | | C04 | | C05 | | C01=External-beam radiation therapy (palliative)|C02=External-beam radiation therapy (palliative) + limb stabilization (prevention of pathological fractures)<br>Denosumab or biophosphonate therapy should be considered|C03=External-beam radiation therapy (palliative)|C04=Click here for the treatment of stage IV M1b (solitary site metastasis)|C05=Click here for the treatment of metastatic disease}}
{{familytree | |`|-|-|-|+|-|-|-|'| | | | | | |}}
{{familytree | | | | | D01 | | | | | | | | | | D01=Click here for the treatment of metastatic disease}}
{{familytree/end}}


==Metastatic disease==
A German study has shown that 1-2% of the population meet all the diagnostic criteria of BDD, with a larger percentage showing milder symptoms of the disorder (''Psychological Medicine'', vol 36, p 877). Chronically low self-esteem is characteristic of those with BDD due to the value of oneself being so closely linked with their perceived appearance. The prevalence of BDD is equal in men and women, and causes chronic social [[anxiety]] for those suffering from the disorder[http://www.lipo.com/Health_Articles/Lifestyle_Articles/When_the_mirror_lies_-_Body_dysmorphic_disorder_(dysmorphophobia)_on_the_rise_and_taking_lives./].


{{familytree/start}}
Phillips & Menard (2006) found the completed suicide rate in patients with BDD to be 45 times higher than in the general US population. This rate is more than double that of those with [[Clinical depression]] and three times as high as those with [[bipolar disorder]]<ref>http://ajp.psychiatryonline.org/cgi/content/full/163/7/1280</ref>. There has also been a suggested link between undiagnosed BDD and a higher than average suicide rate among people who have undergone cosmetic surgery<ref>http://www.newscientist.com/channel/health/mg19225745.200-cosmetic-surgery-special-when-looks-can-kill.html</ref>.
{{familytree | | | | | | | | | | A01 | | | | | A01=What the specific subtype according to the specific histological characteristics of the [[tumor]]?}}
{{familytree | | | | | |,|-|-|-|-|^|-|-|-|-|.| | | |}}
{{familytree | | | | | B01 | | | | | | | | B02 | | | B01=<div style="float: left; text-align: left; width: 14em; padding:1em;">
* [[Adenocarcinoma]]<br>
* [[Large cell carcinoma of the lung]]<br>
* Not specified non-small cell lung cancer</div>|B02=[[Squamous cell carcinoma of the lung|Squamous cell carcinoma]]}}
{{familytree | | | | | |!| | | | | | | | | |!| | | }}
{{familytree | | | | | C01 | | | | | | | | C02 | | | C01=Perform specific [[EGFR]] and ALK [[mutation]] testing: What is the specific [[mutation]]?|C02=Is the patient a smoker or former smoker?}}
{{familytree | |,|-|-|-|+|-|-|-|.| | | | | |!| | |}}
{{familytree | D01 | | D02 | | D03 | | | | D04 | | | D01=Sensitizing [[EGFR]] mutation|D02=ALK mutation|D03=Negative [[EGFR]] and ALK|D04=[[Non small cell carcinoma of the lung medical therapy#Metastatic squamous cell carcinoma|Click here for the squamous cell carcinoma specific treatment]]}}
{{familytree | |!| | | |!| | | |!| | | | |}}
{{familytree | E01 | | E02 | | E03 | | | E01=[[Non small cell carcinoma of the lung medical therapy#Positive sensitizing EGFR mutation|Click here for the sensitizing EGFR mutation specific treatment]]|E02=[[Non small cell carcinoma of the lung medical therapy#Positive ALK mutation|Click here for the specific therapy for the ALK mutation specific treatment]]|E03=[[Non small cell carcinoma of the lung medical therapy#Negative EGRF and ALK or unknown mutation|Click here for the treatment of negative sensitizing EGFR and ALK mutation metastatic disease]]}}
{{familytree/end}}


==Third line therapy==
==Historical Perspective==
The algorithm below shows the third line therapy for metastatic disease according to the 2014 NCCN Non-Small Cell Lung Cancer guidelines.
BDD was first documented in 1886 by the researcher Morselli, who called the condition simply "'''Dysmorphophobia'''". BDD was first recorded/formally recognized in 1997 as a disorder in the [[Diagnostic and Statistical Manual of Mental Disorders|DSM]]; however, in 1987 it was first truly recognized by the [[American Psychiatric Association]].  


{{familytree/start}}
In his practice, [[Sigmund Freud|Freud]] eventually had a patient who would today be diagnosed with the disorder; Russian [[aristocrat]] [[Sergei Pankejeff]], nicknamed "The Wolf Man" by Freud himself in order to protect Pankejeff's identity, had a preoccupation with his nose to an extent that greatly limited his functioning.
{{familytree | | | | | | A01 | | | | | | A01=What is the performance status of the patient?}}
{{familytree | | | |,|-|-|^|-|-|.| | | | |}}
{{familytree | | | B01 | | | | B02 | | | | | | B01=PS 0-2|B02=PS 3-4}}
{{familytree | | | |!| | | | | |!| | | |}}
{{familytree | | | C01 | | | | C02 | | | | | C01=If not previously used, administer any of the following:<br>
* Docetaxel<br>
* Erlotinib<br>
* Gemcitabine<br>
* Pemetrexed
|C02=Administer erlotinib or provide suportive care}}
{{familytree | | | |!| | | | | | | | | | | |}}
{{familytree | | | D01 | | | | | | | | | D01=What is the performance status of the patients after the treatment?}}
{{familytree | |,|-|^|-|.| | | | | |}}
{{familytree | E01 | | E02 | | | | | | E01=PS 0-2 (stable [[tumor]])|E02=PS 3-4 ([[tumor]] progression)}}
{{familytree | |!| | | |!| | | | | | |}}
{{familytree | F01 | | F02 | | | | | F01=Provide supportive care or try experimental treatments|F02=Provide supportive care}}
{{familytree/end}}
<br>
===Chemotherapy followed by radiotherapy===
The list bellow show the options for [[chemotherapy]] followed by [[radiation therapy]] based on the 2014 NCCN Non-Small Cell Lung Cancer guidelines.<ref name="NCCN">http://www.nccn.org/professionals/physician_gls/pdf/nscl.pdf</ref>


* [[Cisplatin]] 100 mg/m<sup>2</sup> on days 1 and 29 + vinblastin 5 mg/m<sup>2</sup> per week on days 1, 8, 15, 22 and 29, then followed by radiation therapy.
==Classification==
* [[Paclitaxel]] 200 mg/m<sup>2</sup> administered for 3 hours in the first day + carboplatin AUC 6 administered in 1 hour and then every 21 days to a total of 2 cycles followed by thoracic radiation therapy.
<br>


===Chemotherapy plus radiotherapy, followed by chemotherapy===
==Pathophysiology==
The list bellow show the options for concomitant [[chemotherapy]] plus [[radiation therapy]] followed by [[chemotherapy]] based on the 2014 NCCN Non-Small Cell Lung Cancer guidelines.<ref name="NCCN">http://www.nccn.org/professionals/physician_gls/pdf/nscl.pdf</ref>
BDD usually develops in adolescence, a time when people are generally most sensitive about their appearance. However, many patients suffer for years before seeking help. When they do seek help through mental health professionals, patients often complain of other symptoms such as depression, social anxiety or obsessive compulsive disorder, but do not reveal their real concern over body image. Most patients cannot be convinced that they have a distorted view of their body image, due to the very limited knowledge of the disorder as compared to OCD or others.


* Cisplatin 50 mg/m<sup>2</sup> on days 1, 8, 29 and 36 + etoposide 50 mg/m<sup>2</sup> through day 1 to 5 and then 29 to 33 + thoracic radiation therapy, then followed by cisplatin 50 mg/m<sup>2</sup> + etoposide 50 mg/m<sup>2</sup> to a total of 2 cycles.
An absolute cause of body dysmorphic disorder is unknown. However research shows that a number of factors may be involved and that they can occur in combination, including:
* Paclitaxel 45 to 50 mg/m<sup>2</sup> once a week + carboplatin AUC 2 + thoracic radiation therapy, then followed by [[Paclitaxel]] 200 mg/m<sup>2</sup> + carboplatin AUC 6 to a total of 2 cycles.
 
'''A chemical imbalance in the brain.''' An insufficient level of [[serotonin]], one of the brain's [[neurotransmitter]]s involved in mood and pain, may contribute to body dysmorphic disorder. Although such an imbalance in the brain is unexplained, it may be hereditary.
'''Obsessive-compulsive disorder.''' BDD often occurs with OCD, where the patient uncontrollably practices ritual behaviors that may literally take over their life. A history of, or [[gene]]tic predisposition to, OCD may make people more susceptible to BDD.
 
'''Generalized anxiety disorder.''' Body dysmorphic disorder may co-exist with generalized anxiety disorder. This condition involves excessive worrying that disrupts the patient's daily life, often causing exaggerated or unrealistic anxiety about life circumstances, such as a perceived flaw or defect in appearance, as in BDD.
 
==Causes==
 
==Differentiating type page name here from other Diseases==
 
== Epidemiology and Demographics ==
''According to Dr Katharine Phillips (2004) :''
 
Although large [[epidemiology|epidemiologic]] surveys of BDD's prevalence have not been done, studies to date indicate that BDD is relatively common in both nonclinical and clinical settings (Phillips & Castle, 2002). Studies in community samples have reported current rates of 0.7% and 1.1%, and studies in nonclinical student samples have reported rates of 2.2%, 4%, and 13% (Phillips & Castle, 2002). A study in a general inpatient setting found that 13% of patients had BDD (Grant, Won Kim, Crow, 2001). Studies in outpatient settings have reported rates of 8%-37% in patients with OCD, 11%-13% in social phobia, 26% in trichotillomania, 8% in major depression, and 14%-42% in atypical major depression (Phillips & Castle, 2002). In one study of atypical depression, BDD was more than twice as common as OCD (Phillips, Nierenberg, Brendel et al 1996), and in another (Perugi, Akiskal, Lattanzi et al, 1998) it was more common than many other disorders, including OCD, social phobia, simple phobia, generalized anxiety disorder, [[bulimia nervosa]], and substance abuse or dependence. In a [[dermatology]] setting, 12% of patients screened positive for BDD, and in [[cosmetic surgery]] settings, rates of 6%-15% have been reported (Phillips & Castle, 2002).
 
BDD is underdiagnosed, however. Two studies of inpatients (Phillips, McElroy, Keck et al, 1993, and Grant, Won Kim, Crow, 2001), as well as studies in general outpatients (Zimmerman & Mattia, 1998) and depressed outpatients (Phillips, Nierenberg, Brendel et al 1996), systematically assessed a series of patients for the presence of BDD and then determined whether clinicians had made the diagnosis in the clinical record. All four studies found that BDD was missed by the clinician in every case in which it was present. Thus, underdiagnosis of BDD appears common.
 
== Risk Factors ==
 
== Screening ==
 
== Natural History, Complications, and Prognosis==
 
== Diagnosis ==
 
=== Symptoms ===
*Compulsive mirror checking, glancing in reflective doors, windows and other reflective surfaces.
*Alternatively, an inability to look at one's own reflection or photographs of oneself; often the removal of mirrors from the home.
*Compulsive skin-touching, especially to measure or feel the perceived defect.
*Reassurance-seeking from loved ones.
*Social withdrawal and co-morbid depression.
*Obsessive viewing of favorite celebrities or models the person suffering from BDD may wish to resemble.
*Excessive grooming behaviors: combing hair, plucking eyebrows, shaving, etc.
*Obsession with [[plastic surgery]] or multiple plastic surgeries with little satisfactory results for the patient.
*In obscure cases patients have performed plastic surgery on themselves, including [[liposuction]] and various implants with disastrous results.
 
===Location of imagined defects===
In research carried out by Dr. Katharine Philips, involving over 500 patients, the percentage of patients concerned with the most common locations were as follows:
{{col-begin}}
{{col-break}}
*skin (73%)
*hair (56%)
*nose (37%)
*weight (22%)
*stomach (22%)
*breasts/chest/nipples (21%)
*eyes (20%)
*thighs (20%)
*teeth (20%)
*legs (overall) (18%)
*body build / bone structure (16%)
*ugly face (general) (14%)
*lips (12%)
*buttocks (12%)
*chin (11%)
*fingers
*eyebrows (11%)
 
''source: '''The Broken Mirror''', Katharine A Philips, Oxford University Press, 2005 ed, p56 ''
 
People with BDD often have more than one area of concern.
 
==The Disabling Effects of BDD==
BDD can be anywhere from slightly to severely debilitating. It can make normal employment or family life impossible. Those who are in regular employment or who have family responsibilities would almost certainly find life more productive and satisfying if they did not have the symptoms. The partners of sufferers of BDD may also become involved and suffer greatly, sometimes losing their loved one to [[suicide]].
 
==Prognosis==
Many individuals with BDD have repeatedly sought treatment from dermatologists or cosmetic surgeons with little satisfaction before finally accepting psychiatric or psychological help. Treatment can improve the outcome of the illness for most people. Other patients may function reasonably well for a time and then relapse, while others may remain chronically ill. Research on outcome without therapy is not known but it is thought the symptoms persist unless treated.  
 
== Treatment ==
Typically the [[psychodynamic]] approach to therapy does not seem to be effective in battling BDD while in some patients it may even be countereffective.
 
CBT ([[Cognitive Behavioral Therapy]]) coupled with [[exposure therapy]] has been shown effective in the treatment of BDD. Low levels or insufficient use of serotonin in the brain has been implicated with the disorder and so [[SSRI]] drugs are commonly used, and with some success, in the treatment of Body Dysmorphic Disorder. Drug treatment will sometimes also include the use of an [[anxiolytic]].
 
BDD tends to be chronic; current information suggests that symptoms do not subside, but rather worsen through time. Indeed in most patients, the symptoms and concerns diversify and social contacts may further deteriorate. As so, treatment should be initiated as early as possible following the diagnoses.
 
==References==
{{reflist|2}}
 
{{WikiDoc Help Menu}}
{{WikiDoc Sources}}
 
[[Category:Disease]]
[[Category:FLK]]

Latest revision as of 01:53, 14 October 2014

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Alonso Alvarado, M.D. [2]

Infobox goes here

{{SI}}

Synonyms and keywords:

Overview

Body dysmorphic disorder (BDD) is a mental disorder that involves a disturbed body image. It is generally diagnosed in those who are extremely critical of their physique or self-image, despite the fact there may be no noticeable disfigurement or defect.

Most people wish they could change or improve some aspect of their physical appearance, but people suffering from BDD, generally considered of normal appearance, believe that they are so unspeakably hideous that they are unable to interact with others or function normally for fear of ridicule and humiliation at their appearance. They tend to be very secretive and reluctant to seek help because they are afraid others will think them vanity|vain or they may feel too embarrassed to do so.

Ironically, BDD is often misunderstood as a vanity driven obsession, whereas it is quite the opposite; people with BDD believe themselves to be irrevocably ugly or defective.

BDD combines obsessive and compulsive aspects, which links it to the OCD spectrum disorders among psychologists. People with BDD may engage in compulsive mirror checking behaviors or mirror avoidance, typically think about their appearance for more than one hour a day, and in severe cases may drop all social contact and responsibilities as they become homebound. The disorder is linked to an unusually high suicide rate among all mental disorders.

A German study has shown that 1-2% of the population meet all the diagnostic criteria of BDD, with a larger percentage showing milder symptoms of the disorder (Psychological Medicine, vol 36, p 877). Chronically low self-esteem is characteristic of those with BDD due to the value of oneself being so closely linked with their perceived appearance. The prevalence of BDD is equal in men and women, and causes chronic social anxiety for those suffering from the disorder[3].

Phillips & Menard (2006) found the completed suicide rate in patients with BDD to be 45 times higher than in the general US population. This rate is more than double that of those with Clinical depression and three times as high as those with bipolar disorder[1]. There has also been a suggested link between undiagnosed BDD and a higher than average suicide rate among people who have undergone cosmetic surgery[2].

Historical Perspective

BDD was first documented in 1886 by the researcher Morselli, who called the condition simply "Dysmorphophobia". BDD was first recorded/formally recognized in 1997 as a disorder in the DSM; however, in 1987 it was first truly recognized by the American Psychiatric Association.

In his practice, Freud eventually had a patient who would today be diagnosed with the disorder; Russian aristocrat Sergei Pankejeff, nicknamed "The Wolf Man" by Freud himself in order to protect Pankejeff's identity, had a preoccupation with his nose to an extent that greatly limited his functioning.

Classification

Pathophysiology

BDD usually develops in adolescence, a time when people are generally most sensitive about their appearance. However, many patients suffer for years before seeking help. When they do seek help through mental health professionals, patients often complain of other symptoms such as depression, social anxiety or obsessive compulsive disorder, but do not reveal their real concern over body image. Most patients cannot be convinced that they have a distorted view of their body image, due to the very limited knowledge of the disorder as compared to OCD or others.

An absolute cause of body dysmorphic disorder is unknown. However research shows that a number of factors may be involved and that they can occur in combination, including:

A chemical imbalance in the brain. An insufficient level of serotonin, one of the brain's neurotransmitters involved in mood and pain, may contribute to body dysmorphic disorder. Although such an imbalance in the brain is unexplained, it may be hereditary.

Obsessive-compulsive disorder. BDD often occurs with OCD, where the patient uncontrollably practices ritual behaviors that may literally take over their life. A history of, or genetic predisposition to, OCD may make people more susceptible to BDD.

Generalized anxiety disorder. Body dysmorphic disorder may co-exist with generalized anxiety disorder. This condition involves excessive worrying that disrupts the patient's daily life, often causing exaggerated or unrealistic anxiety about life circumstances, such as a perceived flaw or defect in appearance, as in BDD.

Causes

Differentiating type page name here from other Diseases

Epidemiology and Demographics

According to Dr Katharine Phillips (2004) :

Although large epidemiologic surveys of BDD's prevalence have not been done, studies to date indicate that BDD is relatively common in both nonclinical and clinical settings (Phillips & Castle, 2002). Studies in community samples have reported current rates of 0.7% and 1.1%, and studies in nonclinical student samples have reported rates of 2.2%, 4%, and 13% (Phillips & Castle, 2002). A study in a general inpatient setting found that 13% of patients had BDD (Grant, Won Kim, Crow, 2001). Studies in outpatient settings have reported rates of 8%-37% in patients with OCD, 11%-13% in social phobia, 26% in trichotillomania, 8% in major depression, and 14%-42% in atypical major depression (Phillips & Castle, 2002). In one study of atypical depression, BDD was more than twice as common as OCD (Phillips, Nierenberg, Brendel et al 1996), and in another (Perugi, Akiskal, Lattanzi et al, 1998) it was more common than many other disorders, including OCD, social phobia, simple phobia, generalized anxiety disorder, bulimia nervosa, and substance abuse or dependence. In a dermatology setting, 12% of patients screened positive for BDD, and in cosmetic surgery settings, rates of 6%-15% have been reported (Phillips & Castle, 2002).

BDD is underdiagnosed, however. Two studies of inpatients (Phillips, McElroy, Keck et al, 1993, and Grant, Won Kim, Crow, 2001), as well as studies in general outpatients (Zimmerman & Mattia, 1998) and depressed outpatients (Phillips, Nierenberg, Brendel et al 1996), systematically assessed a series of patients for the presence of BDD and then determined whether clinicians had made the diagnosis in the clinical record. All four studies found that BDD was missed by the clinician in every case in which it was present. Thus, underdiagnosis of BDD appears common.

Risk Factors

Screening

Natural History, Complications, and Prognosis

Diagnosis

Symptoms

  • Compulsive mirror checking, glancing in reflective doors, windows and other reflective surfaces.
  • Alternatively, an inability to look at one's own reflection or photographs of oneself; often the removal of mirrors from the home.
  • Compulsive skin-touching, especially to measure or feel the perceived defect.
  • Reassurance-seeking from loved ones.
  • Social withdrawal and co-morbid depression.
  • Obsessive viewing of favorite celebrities or models the person suffering from BDD may wish to resemble.
  • Excessive grooming behaviors: combing hair, plucking eyebrows, shaving, etc.
  • Obsession with plastic surgery or multiple plastic surgeries with little satisfactory results for the patient.
  • In obscure cases patients have performed plastic surgery on themselves, including liposuction and various implants with disastrous results.

Location of imagined defects

In research carried out by Dr. Katharine Philips, involving over 500 patients, the percentage of patients concerned with the most common locations were as follows: